G. Rogers

发表

Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model.

S. Sharma, P. Burke, K. Bagshawe, 1990, British Journal of Cancer.

Galactosylated antibodies and antibody‐enzyme conjugates in antibody‐directed enzyme prodrug therapy

C. Springer, S. Sharma, G. T. Rogers, 1994, Cancer.

Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspects.

S. Sharma, C. Springer, K. Bagshawe, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

ANTIBODY-ENZYME CONJUGATES CAN GENERATE CYTOTOXIC DRUGS FROM INACTIVE PRECURSORS AT TUMOR SITES

K. Bagshawe, R. Sherwood, P. Burke, 1991 .

Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice.

R. Sherwood, F. Searle, P. Burke, 1990, British Journal of Cancer.

Dose-dependent localisation and potential for therapy of F(ab')2 fragments against CEA studied in a human tumour xenograft model.

R. Pedley, J. Boden, K. Bagshawe, 1986, British Journal of Cancer.

Dose dependent localisation of a monoclonal F(ab')2 fragment against CEA in the mouse xenograft model.

R. Pedley, J. Boden, K. Bagshawe, 1986, European journal of cancer & clinical oncology.

Extraction and preliminary characterization of a human bronchogenic carcinoma antigen.

M. Frost, K. Bagshawe, G. Rogers, 1975, British Journal of Cancer.

Antibody directed enzyme prodrug therapy (ADEPT): clinical report.

C. Springer, S. Sharma, K. Bagshawe, 1991, Disease markers.

Antibody directed enzyme prodrug therapy (ADEPT): a three phase system.

C. Springer, S. Sharma, K. Bagshawe, 1991, Disease markers.

Blood carcinoembryonic antigen, Regan isoenzyme, and human chorionic gonadotrophin in primary mediastinal carcinoma.

K. Bagshawe, F. Searle, G. Rogers, 1973, Lancet.

Heterogeneity and specificity of circulating carcinoembryonic antigen.

F. Searle, K. Bagshawe, B. A. Leake, 1977, European journal of cancer.

Carcinoembryonic antigen: isolation of a sub-fraction with high specific activity.

F. Searle, K. Bagshawe, G. Rogers, 1976, British Journal of Cancer.

Heterogeneity of carcinoembryonic antigen and its fractionation by con A affinity chromatography

F. Searle, G. Rogers, K. D. BAGSHAWE, 1974, Nature.

Application of monoclonal antibodies to purified CEA in clinical radioimmunoassay of human serum.

E. Cooper, P. Keep, K. Bagshawe, 1981, British Journal of Cancer.

Somatic-cell hybrids producing antibodies against CEA.

K. Bagshawe, G. Rogers, G. Rawlins, 1981, British journal of cancer.

acidanditsactive parent druginmice

R. Sherwood, F. Searle, P. Burke, 1990 .

Dynamics of monoclonal antibody distribution and prolonged tumour localisation in nude mice bearing a human CEA-producing colon carcinoma xenograft.

R. Pedley, J. Boden, K. Bagshawe, 1986, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Plasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo.

S. Sharma, G. T. Rogers, P. Burke, 1995, British Journal of Cancer.

Application of monoclonal antibodies to purified CEA in clinical radioimmunoassay of human serum.

E. Cooper, P. Keep, K. Bagshawe, 1981, British Journal of Cancer.

ANTIBODY DIRECTED ENZYME PRODRUG THERAPY (ADEPT) IN HUMAN TUMOR XENOGRAFT MODELS

P. Burke, K. Bagshawe, R. Sherwood, 1990 .

Somatic-cell hybrids producing antibodies against CEA.

K. Bagshawe, G. Rogers, G. Rawlins, 1981, British Journal of Cancer.